Ebola Vaccine Trial (Ad26.ZEBOV/MVA-BN-Filo)
Condition:   Ebola Virus Disease Intervention:   Drug: Ad26.ZEBOV/MVA-BN-Filo Sponsors:   MRC/UVRI Uganda Research Unit on Aids;   Epicentre, Paris, France and Mbarara, Uganda;   Janssen Pharmaceutica N.V., Belgium;   Coalition for Epidemic Preparedness Innovations Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials

Harm Reduction Program For Informal PrEP Users In A Community-based Setting (seguiPrEP)
Conditions:   HIV/AIDS;   HIV Infections;   Sexually Transmitted Diseases;   Vaccination;   Adherence, Medication;   Side Effect of Drug;   Preexposure Prophylaxis Interventions:   Behavioral: Harm reduction of informal PrEP use;   Other: PrEP follow up based on point of care testing Sponsors:   BCN Checkpoint;   Projecte dels NOMS-Hispanosida (BCN Checkpoint and BCN PrEP·Point);   Fundacio Lluita Contra la SIDA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2019 Category: Research Source Type: clinical trials